Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,16071,753,1.03 [0.89-1.19],0.7085295876965547
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,15495,237,1.01 [0.78-1.32],0.9324902717062676
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,18121,149,0.83 [0.57-1.22],0.3401124368061931
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,11287,850,0.99 [0.85-1.15],0.9104687616756456
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,18082,110,0.97 [0.65-1.43],0.8705283250855429
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,16156,76,0.93 [0.56-1.53],0.7690993291676183
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",19260,109,0.98 [0.67-1.45],0.9293195147927812
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,19248,75,1.06 [0.69-1.63],0.7996901999263437
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,15744,54,1.04 [0.61-1.76],0.8987190352338137
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,18361,107,0.98 [0.66-1.46],0.9246273062860428
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,18323,69,0.87 [0.50-1.50],0.6089591004718613
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,19328,60,0.64 [0.32-1.26],0.1953392873504854
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,19371,51,1.09 [0.66-1.80],0.7327195733682033
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",19369,49,1.11 [0.67-1.84],0.6876568991435161
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Mycoses,18976,50,1.15 [0.71-1.85],0.5662921903898638
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",18086,357,1.02 [0.83-1.25],0.8576617502199905
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,17846,117,0.96 [0.66-1.41],0.8352022089733391
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,17987,258,1.00 [0.78-1.28],0.9766381754295856
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",13994,82,0.74 [0.43-1.29],0.2902951672412005
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",13960,48,1.23 [0.79-1.91],0.3635561569405341
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",14239,327,1.01 [0.81-1.26],0.9306160343990396
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",14247,335,0.99 [0.79-1.24],0.9263174219686748
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",8042,315,0.92 [0.72-1.17],0.4939551485531679
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",6354,169,1.06 [0.79-1.42],0.6890704467778355
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",13958,46,1.09 [0.63-1.87],0.753637151666901
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,16616,601,0.99 [0.84-1.17],0.9085730474655817
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",18085,385,0.81 [0.63-1.03],0.0836268618295376
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,18900,133,0.66 [0.42-1.05],0.0783492752368582
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",19406,122,0.69 [0.43-1.10],0.1166769126744439
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign neoplasm: Rectum,19137,77,0.98 [0.61-1.56],0.9243192369023286
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,19411,77,0.77 [0.45-1.34],0.3632282723751315
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign neoplasm: Stomach,19459,55,0.64 [0.31-1.31],0.2253073035638747
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign lipomatous neoplasm,19261,245,0.63 [0.45-0.89],0.0088190479502519
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,19438,87,0.57 [0.31-1.03],0.0610416335265612
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,19443,73,0.51 [0.26-1.00],0.0509160755881989
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",19370,49,0.74 [0.36-1.49],0.3968998433576902
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Haemangioma, any site",19373,48,0.70 [0.34-1.46],0.3453893325511693
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Melanocytic naevi,19320,125,0.91 [0.62-1.34],0.628122669063186
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,19439,56,0.87 [0.48-1.58],0.6461724922009519
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Other benign neoplasms of skin,19335,147,1.14 [0.86-1.51],0.3741443012137637
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign neoplasm of breast,10241,39,0.86 [0.42-1.75],0.6746359554174791
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Leiomyoma of uterus,10113,258,0.91 [0.69-1.18],0.4655225093091972
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,18185,157,0.85 [0.59-1.22],0.3869375677991647
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,17755,265,0.92 [0.71-1.20],0.5487484200188602
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,17755,265,0.92 [0.71-1.20],0.5487484200188602
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),15680,436,1.23 [1.04-1.44],0.0135500614089862
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,18956,50,1.01 [0.58-1.77],0.971319867649914
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,19181,46,0.35 [0.14-0.87],0.0241321352514398
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,14135,1293,1.06 [0.95-1.19],0.2805101354390152
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,18044,528,0.97 [0.81-1.17],0.7749832251376558
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,17117,114,0.84 [0.54-1.29],0.4187537615805043
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,18131,137,1.20 [0.90-1.61],0.2118210169790501
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,17108,105,0.85 [0.55-1.33],0.4822308164431524
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,17624,621,0.98 [0.82-1.16],0.7778405476984942
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,17605,602,0.98 [0.83-1.16],0.8234376188762891
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,17944,143,0.95 [0.64-1.41],0.793703025556795
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",17943,142,0.95 [0.64-1.41],0.7933509078619854
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,13987,1145,1.05 [0.93-1.19],0.402782938409688
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",12983,141,0.63 [0.40-1.00],0.0483417310108379
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,13906,1064,1.08 [0.95-1.22],0.2204222146346329
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,12884,42,1.11 [0.62-1.98],0.7261465412345345
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",12912,70,1.26 [0.85-1.87],0.2468458741861433
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,Any mental disorder,16012,427,0.96 [0.78-1.18],0.7244505423552304
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",15718,133,1.12 [0.81-1.56],0.4768234619124776
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",19152,92,1.20 [0.85-1.69],0.3064668908225577
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",19201,67,1.24 [0.85-1.82],0.2605693124065902
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,18172,30,0.93 [0.43-2.03],0.8543525505303184
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",19392,30,0.90 [0.41-2.00],0.7982402990147512
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",15615,30,0.93 [0.43-2.05],0.8662042528966494
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,Alcohol dependence,18178,36,1.37 [0.89-2.12],0.1529472536897452
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,Smoking dependency,18128,43,1.00 [0.56-1.77],0.9971752671384532
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",15613,28,1.09 [0.55-2.17],0.8120021566860346
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",15785,200,1.01 [0.77-1.34],0.9288423107489432
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,Depression,18285,180,1.00 [0.74-1.35],0.993531867330317
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,Depression or dysthymia,15511,156,0.95 [0.68-1.33],0.7646751751312877
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",15672,87,0.77 [0.46-1.29],0.3219468410257901
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,Other anxiety disorders,18280,53,0.49 [0.22-1.08],0.0786138375803848
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Neurological diseases,16040,1225,0.86 [0.76-0.99],0.0307149670761002
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,14089,84,0.65 [0.37-1.15],0.1418509516428931
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,19386,63,0.57 [0.28-1.15],0.1155036229292675
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,18390,374,0.88 [0.69-1.10],0.2600489656020091
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Epilepsy,18117,101,1.08 [0.74-1.55],0.6970391114438543
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Migraine,18064,48,1.01 [0.57-1.79],0.9693062787984538
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",19267,43,1.10 [0.64-1.91],0.7272264662516833
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,18515,95,0.88 [0.55-1.39],0.5740649562180818
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Other sleep disorders,18145,129,0.72 [0.46-1.12],0.140915969964519
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Sleep apnoea,19037,98,0.69 [0.41-1.16],0.1650112293979252
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",18473,585,0.89 [0.74-1.07],0.1999812133912054
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",17974,86,0.84 [0.51-1.38],0.4938381842652465
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,18245,357,0.99 [0.80-1.22],0.9060285845283068
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,19162,64,0.95 [0.56-1.60],0.8337646343352104
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Hemiplegia,19146,48,0.78 [0.39-1.57],0.4950147969392535
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Other neurological diseases,19007,95,0.90 [0.58-1.42],0.6608085846191715
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",18748,355,0.98 [0.79-1.22],0.8482327744951568
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,18607,214,0.80 [0.58-1.11],0.1750406372340834
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,18445,52,1.34 [0.91-1.96],0.1353043306036047
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,18504,111,0.82 [0.53-1.28],0.3884805918848191
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,18478,85,0.96 [0.61-1.50],0.8435312037016417
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,14944,209,1.23 [0.97-1.55],0.0889027194837893
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,15251,516,1.02 [0.85-1.22],0.8515116200012692
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,18298,237,1.13 [0.90-1.42],0.2935852061111661
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,19105,51,1.05 [0.62-1.78],0.857198580121408
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,2155,51,1.16 [0.66-2.04],0.5976123425730305
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",17001,51,1.07 [0.64-1.80],0.7855861944063195
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,18630,114,0.98 [0.67-1.45],0.9362144932183756
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,18575,59,0.82 [0.44-1.51],0.5186818168428202
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",18694,58,1.31 [0.91-1.89],0.1445899172204197
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,18901,81,0.84 [0.51-1.40],0.5134928223882891
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,19384,111,1.01 [0.69-1.47],0.9778242523667772
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,18495,96,0.94 [0.61-1.44],0.766678652942998
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,12004,3702,0.95 [0.87-1.04],0.2436970969561943
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,18688,80,0.92 [0.56-1.49],0.7261619507002095
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",12767,2574,0.96 [0.87-1.06],0.423597478114276
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Hypertension,12791,2598,0.96 [0.87-1.05],0.3612203793457194
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,10253,60,0.60 [0.30-1.21],0.1551252560285969
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",17089,1465,1.03 [0.92-1.14],0.6511095641295481
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Angina pectoris,16497,873,1.10 [0.96-1.25],0.1681485169326505
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,18317,270,1.28 [1.06-1.55],0.0090122592271472
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,18600,553,1.15 [0.99-1.34],0.0615664917052417
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",19321,111,1.21 [0.90-1.63],0.2091381469783115
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",15973,349,1.06 [0.86-1.30],0.572805810050963
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,16775,1171,1.02 [0.91-1.16],0.7018171004224577
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,18497,113,1.07 [0.76-1.52],0.6843859712150924
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,18696,237,0.99 [0.76-1.29],0.9290512775031964
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,18490,106,1.22 [0.90-1.66],0.2046546587538896
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,18491,107,1.21 [0.89-1.65],0.2245287189198923
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",10295,102,1.26 [0.92-1.74],0.1478063634823403
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,14462,61,0.90 [0.51-1.57],0.7004244618440129
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Conduction disorders,14538,137,0.97 [0.68-1.38],0.8738811626012437
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,7738,111,0.67 [0.41-1.11],0.1174975487889488
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,8188,561,0.91 [0.75-1.11],0.3632542744653037
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other arrhythmias,14479,78,0.85 [0.51-1.42],0.5393953398824904
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,14509,108,1.03 [0.71-1.50],0.8618649458312767
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",18134,238,0.91 [0.69-1.21],0.5156422339676154
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",18427,156,0.71 [0.47-1.07],0.1026358952038558
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",18455,140,0.76 [0.50-1.15],0.1974482724676765
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",18542,122,0.89 [0.60-1.33],0.5796889107698278
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,18106,83,1.33 [0.98-1.79],0.0634229571867287
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,18169,146,0.97 [0.68-1.37],0.8549049677123746
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),18046,140,0.93 [0.65-1.32],0.6825387744134757
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,18024,118,1.00 [0.70-1.44],0.98057310777733
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",19219,113,0.99 [0.68-1.45],0.9716555908164376
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Varicose veins,18336,430,0.99 [0.82-1.21],0.95869841606856
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Hypotension,18136,93,1.05 [0.71-1.55],0.8170647471615313
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,14414,1806,0.94 [0.85-1.05],0.257679022849441
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,19329,71,1.01 [0.64-1.61],0.961360202182313
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,17416,224,1.03 [0.79-1.34],0.822533589183732
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",17390,198,1.06 [0.81-1.39],0.6819216664916519
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,18438,242,0.73 [0.53-1.01],0.0542679579405499
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,18432,236,0.76 [0.56-1.05],0.0968670673216548
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,18845,463,0.96 [0.79-1.16],0.6665904008998818
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Chronic sinusitis,18459,77,0.77 [0.44-1.34],0.3563507733456704
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Nasal polyp,18498,116,0.96 [0.65-1.40],0.818502619739768
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",18672,290,0.98 [0.77-1.25],0.8755165655661961
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Deviated nasal septum,18498,116,1.07 [0.76-1.50],0.7043033771861367
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,6262,63,0.97 [0.58-1.62],0.9025681972658108
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,16822,942,0.95 [0.83-1.10],0.5040178195768368
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Early onset COPD,18088,205,1.10 [0.86-1.41],0.4507539811357323
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",18128,245,1.05 [0.82-1.34],0.694425947980515
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",18128,245,1.05 [0.82-1.34],0.694425947980515
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",18017,713,0.96 [0.82-1.12],0.6102165441163396
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Asthma,12725,713,0.96 [0.82-1.12],0.5856271281303487
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",12412,713,0.96 [0.82-1.12],0.6026166932708925
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",12718,706,0.96 [0.82-1.13],0.6511177539030907
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,18975,119,1.17 [0.85-1.60],0.3347719450927191
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Interstitial lung disease,18062,93,1.13 [0.78-1.64],0.5038333367617187
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",19053,93,1.13 [0.79-1.63],0.5033108306508794
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,18055,86,1.01 [0.66-1.56],0.9559798141357968
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Pleural effusion,17137,115,0.96 [0.65-1.41],0.823943704503547
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Other diseases of pleura,17265,243,0.94 [0.71-1.24],0.664046962269542
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,18063,114,0.65 [0.39-1.07],0.0882750192647316
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,12570,5338,0.98 [0.91-1.05],0.5757753029047594
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",19081,286,0.75 [0.56-1.00],0.0500123716431845
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,19460,31,0.73 [0.29-1.79],0.4888325482918723
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Impacted teeth,19461,29,0.64 [0.24-1.72],0.3777216338411384
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Dental caries,18880,85,0.82 [0.49-1.36],0.4448365780016983
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,18868,73,0.65 [0.35-1.21],0.1741988368490388
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,19456,34,0.72 [0.30-1.71],0.4607189695769396
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,18875,80,0.76 [0.44-1.31],0.3198582175046931
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,18649,78,0.92 [0.57-1.50],0.7477142184081784
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,19366,51,0.98 [0.56-1.73],0.9529740918878254
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,13810,273,0.98 [0.77-1.25],0.8700030637463908
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",15655,2118,1.02 [0.93-1.11],0.7044596829955241
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Oesophagitis,13875,338,1.13 [0.94-1.37],0.184553293189448
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,14233,696,0.99 [0.85-1.15],0.8788739976558865
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,13606,69,1.29 [0.91-1.81],0.1505965393822523
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,13770,233,1.28 [1.06-1.55],0.0116665357817989
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,13609,72,0.82 [0.47-1.42],0.4709574043099532
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Gastric ulcer,13695,158,1.07 [0.80-1.43],0.6541940395741495
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Duodenal ulcer,13659,122,0.89 [0.59-1.33],0.5605198314341339
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",19319,86,0.98 [0.63-1.51],0.9142503609222642
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Chronic gastritis,13652,115,0.87 [0.57-1.32],0.5113364669078452
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),14345,808,1.02 [0.88-1.17],0.8300082013194414
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Diseases of appendix,19344,78,0.78 [0.45-1.34],0.3644970541831404
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Functional dyspepsia,13935,398,1.10 [0.92-1.31],0.3069635225131474
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,13723,186,0.77 [0.54-1.10],0.1512805386152869
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,19339,102,1.19 [0.86-1.64],0.2868620631220681
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Acute appendicitis,19333,67,0.83 [0.47-1.45],0.510323485540753
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Hernia,16450,1708,1.05 [0.95-1.16],0.3116649012883352
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Inguinal hernia,15415,673,1.01 [0.86-1.18],0.9382438034183394
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Umbilical hernia,14846,104,0.68 [0.41-1.13],0.140063512802243
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Ventral hernia,14830,88,1.30 [0.94-1.80],0.1087831247692783
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,15665,923,1.10 [0.98-1.25],0.1114535125724412
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,18564,640,1.01 [0.86-1.18],0.9153250270825388
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of intestines,14336,1934,0.97 [0.87-1.07],0.4967691601479109
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",19173,41,0.49 [0.20-1.20],0.1182595134593718
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",19412,51,0.43 [0.19-1.00],0.0499027455661024
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Crohn disease,17975,51,0.44 [0.19-1.00],0.0512521395341466
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,17961,37,0.26 [0.09-0.75],0.0124394429191019
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",19345,120,0.99 [0.69-1.42],0.9561376926523508
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Ulcerative colitis,18044,120,0.99 [0.69-1.42],0.9616275429496388
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",18035,111,0.95 [0.64-1.41],0.801019965600988
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,18449,525,1.01 [0.85-1.20],0.883369866740265
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,18441,517,1.02 [0.86-1.21],0.8103837463412773
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,12512,110,0.92 [0.61-1.39],0.7046806191555195
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Intestinal stricture,18967,110,0.93 [0.62-1.40],0.7353914419152054
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",12472,70,0.92 [0.55-1.54],0.7394475163809655
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,13142,740,0.89 [0.75-1.05],0.1594243519959733
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,12536,134,0.82 [0.54-1.22],0.3232934929017655
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,12663,261,1.03 [0.81-1.31],0.8092383817737826
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Constipation,17760,238,1.08 [0.85-1.37],0.5503443812418243
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,19065,77,0.93 [0.58-1.51],0.782013910848441
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,12493,91,1.14 [0.79-1.64],0.4779170305287993
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,12445,43,0.37 [0.15-0.96],0.0405285155009135
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,13204,802,1.08 [0.94-1.23],0.2743869579945522
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of intestine,12713,311,0.97 [0.76-1.23],0.7853064025193419
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,19052,64,0.92 [0.54-1.57],0.7663107131128619
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Diseases of liver,18698,98,1.11 [0.77-1.59],0.5877501838975613
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of liver,18652,52,0.95 [0.53-1.68],0.8536209654999213
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",18212,588,0.91 [0.76-1.08],0.2784864648393891
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Cholelithiasis,18096,472,0.86 [0.70-1.06],0.1493815456890126
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Cholecystitis,17728,104,0.98 [0.66-1.46],0.9326721051990036
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,17666,42,0.67 [0.30-1.50],0.3285451875028329
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Acute pancreatitis,17685,61,1.20 [0.80-1.81],0.3707170785338151
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),19303,61,1.22 [0.81-1.83],0.3408520577035404
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,18205,274,0.95 [0.74-1.23],0.7204344798264792
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,17987,56,1.25 [0.81-1.92],0.307159467800448
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Coeliac disease,17979,48,1.27 [0.81-2.00],0.2976634805457653
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",17976,45,0.70 [0.33-1.50],0.3610694490059721
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,18109,178,0.95 [0.69-1.31],0.752332119366132
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,GI-bleeding,18102,171,0.96 [0.70-1.33],0.8251931512694656
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,16397,1352,0.92 [0.81-1.04],0.1661321916177351
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,19021,94,0.84 [0.52-1.35],0.4749921284496136
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,19110,370,0.90 [0.71-1.13],0.3428130317778923
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,17766,519,1.00 [0.84-1.20],0.9634918969367544
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,18595,321,0.93 [0.74-1.18],0.5747223787902518
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",18332,58,1.10 [0.69-1.73],0.6968084856819596
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,18502,228,0.93 [0.70-1.24],0.6351543801255126
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,19194,81,1.10 [0.74-1.65],0.624719154199983
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,19171,58,1.23 [0.82-1.86],0.3159185993495502
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,19161,48,1.25 [0.81-1.95],0.3160809353886629
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,19111,63,0.97 [0.58-1.62],0.8996833428910962
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,19110,62,0.83 [0.46-1.49],0.5289817670056298
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,18784,44,0.96 [0.52-1.79],0.902914481898567
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,19047,307,0.89 [0.70-1.15],0.380178814387479
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,17345,98,0.79 [0.49-1.28],0.343227073958347
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,17331,84,1.23 [0.88-1.72],0.2206181215127884
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,17305,58,1.12 [0.71-1.76],0.636138220205638
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",17438,191,0.89 [0.64-1.22],0.4549466622963061
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,17425,178,0.91 [0.66-1.26],0.5796935925151103
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,12754,3693,0.92 [0.85-1.00],0.0527883816155766
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,14101,2295,0.95 [0.86-1.04],0.2539408840549726
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,17280,1101,0.87 [0.75-0.99],0.0417278974062854
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,11956,150,0.93 [0.66-1.32],0.69414607504046
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,12270,464,0.83 [0.66-1.03],0.0908535735241753
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",19027,144,0.97 [0.69-1.37],0.8797887957923223
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,19031,132,1.00 [0.71-1.42],0.9779052341294848
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,13160,1354,0.93 [0.82-1.05],0.2193619548528147
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",15281,1354,0.92 [0.82-1.04],0.1987216386672659
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,11881,75,0.96 [0.58-1.56],0.8568595311040496
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",18844,72,0.91 [0.55-1.51],0.7221454483193621
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,12032,226,0.70 [0.50-0.99],0.04340198161109
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,11902,96,0.76 [0.47-1.25],0.2822702843245431
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,12182,376,1.05 [0.86-1.28],0.6074844984998189
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",19270,189,1.04 [0.78-1.37],0.8031731259887749
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,12402,596,0.89 [0.74-1.08],0.232580846867088
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,12262,456,0.81 [0.65-1.02],0.0678734997577828
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,12925,1119,0.89 [0.78-1.02],0.0948141487822142
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),11891,85,0.95 [0.61-1.49],0.8215789636076273
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),12048,242,1.01 [0.79-1.30],0.9316310528650028
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,11871,65,1.02 [0.63-1.65],0.9269836463847392
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),11882,76,0.47 [0.24-0.92],0.0272100516646899
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,12177,371,0.91 [0.73-1.15],0.4370282994019573
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,12139,333,0.92 [0.73-1.17],0.5062833478662251
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,14671,230,0.61 [0.43-0.88],0.0076529314701327
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,18837,101,1.16 [0.83-1.63],0.3813417766352883
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,18797,61,0.91 [0.52-1.58],0.727504422690118
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,16178,67,0.94 [0.56-1.58],0.8077860281086904
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,16427,316,1.05 [0.85-1.31],0.6401808287461097
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,16900,789,0.95 [0.81-1.11],0.5016660569518008
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,16316,205,1.11 [0.86-1.43],0.4314733519387735
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,16208,97,0.85 [0.53-1.36],0.4951094491367792
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",16698,587,0.92 [0.76-1.10],0.3382211877339409
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,16148,37,1.36 [0.87-2.10],0.1733908616054076
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,16291,180,0.93 [0.68-1.28],0.6563440434963201
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,16183,72,0.92 [0.56-1.53],0.7559142940577567
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,16180,69,0.70 [0.38-1.30],0.2595166417775769
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,16219,108,1.21 [0.89-1.65],0.2278773995116917
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,16161,50,0.83 [0.43-1.60],0.585050523798142
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,16356,245,0.76 [0.56-1.05],0.0931583020604757
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,16466,287,0.79 [0.59-1.04],0.0977178400483821
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,16248,69,0.77 [0.43-1.38],0.3797987836680959
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,16286,107,0.68 [0.41-1.11],0.1244235582477132
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,16249,70,0.95 [0.58-1.56],0.8377718928991518
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",16216,37,0.81 [0.38-1.75],0.5951865847674077
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,16319,140,0.95 [0.67-1.36],0.7822990151217408
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],16312,133,0.99 [0.69-1.40],0.9375859135348742
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,16426,247,0.74 [0.54-1.02],0.0624914645642923
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,16229,50,1.18 [0.74-1.89],0.4919557508456135
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,16262,83,0.74 [0.43-1.28],0.2832794768308883
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,16294,115,0.80 [0.52-1.25],0.3294720168973662
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,16222,43,0.88 [0.45-1.72],0.6992082038339401
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",16567,388,0.85 [0.67-1.07],0.1661525077088753
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,16339,160,0.79 [0.54-1.15],0.2138606862785936
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,16399,220,0.81 [0.59-1.11],0.1938220792516876
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,17498,202,0.78 [0.56-1.10],0.155940624538784
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,17653,357,0.80 [0.62-1.02],0.0767847139686707
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,17328,32,0.51 [0.19-1.41],0.1968811654926001
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,17334,38,1.41 [0.95-2.11],0.0885106597246805
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,17364,68,1.16 [0.78-1.74],0.4585140126589668
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,14307,3391,1.01 [0.93-1.09],0.8596536153282417
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,7452,705,0.95 [0.81-1.12],0.5798800729468454
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,16545,200,0.95 [0.71-1.28],0.7454585431977132
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,16406,61,0.73 [0.39-1.38],0.3334792417323251
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,16627,41,0.83 [0.40-1.73],0.6184312863785559
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,16634,48,0.80 [0.40-1.57],0.5128575937787474
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,16639,53,1.24 [0.80-1.90],0.3382765378406815
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,19142,197,1.10 [0.86-1.42],0.4418535515417772
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,18994,61,1.18 [0.78-1.79],0.425018959241761
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,19093,148,1.16 [0.88-1.52],0.3072581518864296
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,19003,58,1.07 [0.66-1.74],0.7780730115073061
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,17103,1002,1.04 [0.92-1.18],0.5370653642951175
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Cystitis,16184,83,0.92 [0.57-1.47],0.7249205505368552
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,16178,77,1.15 [0.79-1.69],0.46604319780386
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,16396,295,1.05 [0.84-1.31],0.6646141996715773
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,16214,113,1.06 [0.75-1.51],0.7342904597408513
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,16727,626,0.99 [0.84-1.16],0.8852278678279658
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,7150,403,1.00 [0.82-1.23],0.9731272060073602
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),6803,56,1.13 [0.71-1.81],0.6045852610084443
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Hydrocele,6799,52,1.36 [0.95-1.95],0.0949054182753622
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",6807,60,0.65 [0.32-1.30],0.2195837796111139
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,6822,75,0.69 [0.38-1.26],0.2322308671553663
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,6838,91,0.82 [0.50-1.34],0.4204767880437016
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,10153,200,0.76 [0.54-1.07],0.1205596342280736
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,10017,64,0.76 [0.41-1.38],0.3661585598849999
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,10022,69,0.67 [0.36-1.24],0.199418176721019
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,10009,56,0.94 [0.55-1.63],0.8320371736936203
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,10127,146,1.04 [0.76-1.42],0.8191231576536518
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,10025,44,0.85 [0.43-1.68],0.6422800308767802
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,10027,46,1.24 [0.80-1.94],0.3358081430513829
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,9397,1552,1.04 [0.94-1.16],0.435500276668706
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Endometriosis,7896,51,1.04 [0.60-1.80],0.891409634130892
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),7884,39,0.88 [0.43-1.79],0.7179724658282636
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,8263,418,1.00 [0.82-1.22],0.9946305023680458
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,7924,79,1.39 [1.01-1.91],0.0412261745589646
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,8248,403,1.08 [0.90-1.31],0.4105412040069398
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,7970,125,1.29 [1.00-1.67],0.0535133829299069
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",8036,191,1.15 [0.89-1.48],0.3013249123091308
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,7859,14,0.75 [0.20-2.80],0.6670848676158507
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,7884,39,1.12 [0.63-2.01],0.7006966650942359
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",10251,53,1.02 [0.60-1.73],0.9487026368991872
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,10253,48,0.98 [0.55-1.74],0.9324717759201744
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,10257,22,0.80 [0.29-2.16],0.6549182805483841
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",10255,26,0.95 [0.43-2.12],0.9064302465200174
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,7910,65,1.14 [0.73-1.78],0.5765491694918206
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,7895,50,1.17 [0.72-1.90],0.5376533068117872
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,7906,61,0.76 [0.40-1.43],0.391165277282081
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Irregular menses,10256,75,0.79 [0.46-1.35],0.3875703776538692
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",8014,169,0.91 [0.66-1.28],0.5999622395091742
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Menorrhagia,7925,80,1.15 [0.78-1.70],0.4782996341820131
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",10258,34,0.83 [0.38-1.82],0.6375004750394874
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,7940,95,0.80 [0.49-1.31],0.3753940818741873
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,7887,42,1.01 [0.55-1.88],0.9636767122230372
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,8395,550,1.09 [0.92-1.28],0.3175435558250766
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",19015,71,1.09 [0.70-1.67],0.7090358327949324
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,16694,548,1.02 [0.87-1.21],0.7864886502653728
